Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
MK-801
MK-801 is a dissociative research chemical reported to resemble PCP and ketamine in its effects. It is classified as habit-forming.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Pharmacology
Pharmacodynamics
MK-801 blocks the NMDA receptor pore, binding within the open ion channel at PCP binding sites and preventing ion flow, including calcium entry. This uncompetitive blockade depends on channel use and membrane voltage.1 In experimental seizure models, MK-801 showed anticonvulsant activity,2 preventing the development of kindled seizures without affecting established kindled seizures. Secondary actions include antagonism of nicotinic acetylcholine receptors3 and inhibition of serotonin and dopamine transporters.
MK-801 has demonstrated neuroprotective effects in cell cultures and animal models of excitotoxic injury. It also reduced rabies virus production approximately 1,000-fold in infected rat cortical neurons through an unknown mechanism, without directly inactivating the virus in a cell-free suspension.
Pharmacokinetics
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
MK-801 has reinforcing and habit-forming potential: rats self-administered injections into the nucleus accumbens and frontal cortex, intraperitoneal administration increased self-stimulation responding, and animals developed conditioned place preference; its rewarding effect was not dependent on dopamine. In rhesus monkeys previously trained to self-administer other drugs, three of four trained with phencyclidine self-administered MK-801,5 whereas none of four trained with cocaine did.
Toxicity
Psychosis Risk
MK-801 is associated with psychotic-spectrum reactions and is particularly prone to producing psychotomimetic effects, including hallucinations, through NMDA receptor blockade. In laboratory animals, a single injection reproduced positive and negative schizophrenia-like symptoms; repeated higher-dose administration also reproduced neurochemical alterations resembling those found in first-episode schizophrenia.
History & Culture
Dizocilpine, also known as MK-801, was discovered by a team at Merck in 1982. Merck pursued its development as a potential neuroprotective agent but later discontinued the program.9…
Legality
References
Source Pages
Citations
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the MK-801 article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.